Kernal Biologics

Kernal Biologics has developed mRNA therapies to treat diseases such as COVID-19 and cancer. Our mRNA therapies instruct specific cells on how to produce their own medicine. Our team has successfully built a biotech company at MIT, Harvard, and major pharmaceutical companies, and possesses deep expertise in the mRNA field.